Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events latest research released supporting new understanding how aorta functions
Navigating EU Joint Clinical Assessments and Joint Scientific Consultations From January 2025 Onward
… medicines is accelerated for EU patients. Whether the new legislation and centralised process will meet these aims … time to perform factual checking of the final report. How Are Companies Responding to Expected Challenges With … joint ownership of regulatory affairs and market access functions on an EU level. Given the timeline and scoping …
… and scientific information demonstrating the value of your new pharma or medical device product. What unmet needs does it address? Your research findings and value must be clearly articulated, … market access process. Incorporate value messages and supporting evidence into a GVD. Follow best practices for …
… life, in countries around the world. Learn more about how RTI Health Solutions can help you with literature …
… sample design so that the results accurately answer your research questions about the population of interest. …
… analysis methods and tools to support your outcomes research , health economics , and epidemiology and safety …
… October 2 - Friday, October 6, 2023 Conference website Research coauthored by RTI Health Solution experts will be … Clinical profile and kidney function of SGLT2i and GLP-1RA new users with CKD and type 2 diabetes in Denmark: a …
… Annual Conference on Vaccinology Research Share on: Wednesday, May 8 - Friday, May 10, 2024 Conference website Research coauthored by RTI Health Solutions experts will be presented at the NFID Annual Conference on Vaccinology Research. Evaluating healthcare professionals' knowledge, …
… Workshop registration Image Bradley Layton, PhD , Senior Research Epidemiologist at RTI-HS, will be participating as a …
… In addition, our statisticians are well versed in outcomes research methods and will work with you to plan and analyze … to quantitatively assess the benefit/risk tradeoff of your new treatment regimen. Healthcare Resource Utilization Our … to demonstrate the cost and healthcare benefits of your new treatment. Exploratory Data Analysis In addition to …
… and its characteristics); safety (safety of asset and how it compares to comparators); and clinical effectiveness. … is accelerated for EU patients in the EU. Whether the new legislation and centralised process will meet these aims … to the EU HTA Regulation (HTAR), which applies to all new oncology drugs and cell and gene therapies beginning …